Don Healey News Today

Adicet Bio, Inc. (NASDAQ:ACET – Get Rating) was the target of a significant increase in short interest during the month of April. As of April 30th, there was short interest totalling 3,170,000 shares, an increase of 16.1% from the April 15th total of 2,730,000 shares. Based on an average daily volume of 483,100 shares, the […]

Adicet Bio, Inc. (NASDAQ:ACET – Get Rating) – Investment analysts at HC Wainwright cut their Q2 2023 EPS estimates for shares of Adicet Bio in a research report issued on Wednesday, May 10th. HC Wainwright analyst E. White now anticipates that the company will earn ($0.73) per share for the quarter, down from their prior […]

Adicet Bio, Inc. (NASDAQ:ACET – Get Rating) – Analysts at Wedbush lifted their FY2023 earnings estimates for shares of Adicet Bio in a report released on Wednesday, May 10th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings per share of ($3.38) for the year, up from their prior forecast of ($3.44). […]

Adicet Bio, Inc. (NASDAQ:ACET – Get Rating) has earned an average rating of “Moderate Buy” from the seven analysts that are presently covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average twelve-month target price among […]

Adicet Bio, Inc. (NASDAQ:ACET – Get Rating)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $11.53 and traded as low as $5.47. Adicet Bio shares last traded at $5.64, with a volume of 339,197 shares changing hands. Analyst Ratings Changes Several research […]

Quick read: Experts at the PDA Annual Meeting highlighted the ways that existing packaging plays a role in containing the products of the future.

Adicet Bio, Inc. (NASDAQ:ACET – Get Rating) has been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a sell rating and four have given a buy rating to the company. The average 12 month target price […]

Adicet Bio (NASDAQ: ACET) recently received a number of ratings updates from brokerages and research firms: 3/17/2023 – Adicet Bio had its “buy” rating reaffirmed by analysts at JMP Securities. They now have a $19.00 price target on the stock. 3/16/2023 – Adicet Bio is now covered by analysts at StockNews.com. They set a “sell” […]

Adicet Bio (NASDAQ:ACET – Get Rating)‘s stock had its “outperform” rating restated by analysts at Wedbush in a report issued on Thursday, Benzinga reports. They currently have a $30.00 target price on the stock. Wedbush’s price objective suggests a potential upside of 303.77% from the stock’s previous close. Wedbush also issued estimates for Adicet Bio’s […]

Don Healey